About the Aventis of Risedronate – Actonel
|
|
|
|
|
|
| About the manufacturer of
Risedronate – Actonel |
Procter and Gamble Pharmaceuticals are a unique Pharmaceutical
company with deep experience and proven capabilities are the
manufacturers of Actonel. Procter and gamble the manufacturer of
Risedronate Actonel because Osteoporosis causes loss of bone mineral
density, and is a disease of aging. More common in women than in
men, osteoporosis may lead to fractures of the spine and hip in
advanced cases. Actonel (Risedronate sodium tablets) is developed by
Procter & Gamble Pharmaceuticals and co-marketed by Procter & Gamble
Pharmaceuticals and Aventis. In clinical trials, Actonel was
generally well tolerated.
Actonel makes a treatment inadvisable in patients with
hypocalcaemia, known hypersensitivity to any component of this
product, or inability to stand or sit upright for at least 30
minutes. Hypocalcaemia and other disturbances of bone and mineral
metabolism should be effectively treated before starting Actonel
therapy. Actonel is not recommended for use in patients with severe
renal impairment. The Alliance for Better Bone Health was an
initiative taken by Procter & Gamble and Aventis in the month of May
in the year 1997.
This was started with a goal and the goal was to spread the message
of bone health and creating awareness about this illness by reaching
out to both patients and doctors from every corner of earth. Aventis
is dedicated to treating and preventing disease by discovering and
developing innovative prescription drugs and human vaccines. Procter
and Gamble Pharmaceuticals Canada and Aventis Pharma Inc jointly
announced the approval and availability of 5mg Actonel (Risedronate
sodium tablets) for the treatment and prevention of post menopausal
osteoporosis.
|
|
|
|
|
